Low-dose chidamide maintenance therapy following allogeneic hematopoietic cell transplantation in T-cell acute lymphoblastic leukemia or lymphomas: a phase II, open-label, multicenter, single-arm trial.

Epidaza (chidamide) - Chipscreen

http://www.ncbi.nlm.nih.gov/pubmed/42518787

Guifang Ouyang; He Huang; Huarui Fu; Jian Yu; Jimin Shi; Lixia Sheng; Lizhen Liu; Weihao Chen; Weijie Cao; Xiaoyu Lai; Yanmin Zhao; Yi Luo; Yi Yu

Jul 29, 2026